Upgrade to SI Premium - Free Trial

Avadel Pharma (AVDL) Misses Q2 EPS by 47c

August 9, 2023 7:10 AM

Avadel Pharma (NASDAQ: AVDL) reported Q2 EPS of ($0.83), $0.47 worse than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Avadel Pharma (AVDL) click here.

Categories

Earnings